Please read or listen to this comprehensive resource capturing the insights of the past physical therapy experts and researchers featured on the Know Stroke Podcast. This synthesizes their collective “magic wand” answers, the obstacles they face, and the predicted “break out moment” with a new playbook for stroke care.
The Future of Stroke Rehabilitation: A “Magic Wand” Resource
Insights from the Know Stroke Podcast’s Top Physical Therapy Experts
As the Know Stroke Podcast approaches its 100th episode, a clear consensus has emerged among the industry’s leading Physical Therapists (PTs) and researchers. While acute stroke care has made massive strides in survival rates, the post-acute care pathway remains fragmented. Through our show’s signature “magic wand” question—asking guests how they would redesign the stroke care pathway—a unified vision for the future has taken shape: stroke must be treated as a chronic condition requiring longitudinal, technology-enabled support.
Enjoy this deep dive, I’m calling After The Pod. It synthesizes these PT experts collective “magic wand” answers, the obstacles they face, and the predicted “break out moment” for stroke care. What you’ll hear to follow is an Ai assisted “brain huddle” built by synthesizing the manuscript on my Slinky Effect chapter from my upcoming book Closure After Stroke, along many of my past articles from my know stroke blog, as well as the show notes and recorded episodes from our Know Stroke Podcast with PT experts you’ll be reintroduced to in this ‘PT brain huddle’.
Listen to this deep dive, then send me your question and feedback please on my Know Stroke Substack. Enjoy! And if you need the app to join in on the chat grab it here:
1. The Collective PT “Magic Wand”: A Deep Dive on a New Model of Stroke Care
While each expert brings a unique specialty—from rehab clinicians, robotics to neuroplasticity—their “magic wand” wishes converge on a single concept: Abandoning the episodic care model in favor of a lifespan approach.
The “Dental Model” of Stroke Care: Dr. Teresa Jacobson Kimberley (PT, PhD) articulates this most clearly. Her wish is for stroke survivors to have access to intense rehabilitation (e.g., six weeks) annually, coupled with check-ups twice a year, similar to how patients see a dentist. This ensures survivors aren’t “dropped off a cliff” after initial discharge but are managed for life.
Movement for the Lifespan: Dr. Jennifaye V. Brown (PT, PhD) echoes this, wishing for PTs to transition from seeing themselves solely as rehabilitation specialists to “movement scientists” who teach survivors how to move and exercise for their entire health span, preventing secondary strokes and sedentary-related diseases.
Optimizing Dosage and Reimbursement: Dr. Arun Jayaraman (PT, PhD) of the Shirley Ryan AbilityLab emphasizes that the current system is capped by insurance rather than patient need. His magic wand would redesign reimbursement to allow for significantly longer therapy durations, noting that “simple therapy works more than anything else if they just were given more chance to do things”.
Comprehensive Policy Mandates: Dr. Pamela Duncan (PhD, PT), drawing on her Compass CP model work, wishes for a system where comprehensive care—including recovery and secondary prevention—is legislatively mandated, similar to models in the UK, ensuring patients are not “parachuted out of the hospital with a hole in the parachute”.
Empathy and “The Waste” of Neuroplasticity: Dr. Mike Studer (DPT) and Dr. David Putrino (PT, PhD) focus on the provider’s mindset. Studer’s magic wand is to ensure no practitioner “wastes neuroplasticity” by failing to understand the science or the patient’s motivation. Putrino takes this further, wishing every researcher and clinician had to live with the condition or care for a survivor for a year to build the empathy required to drive urgent, disruptive innovation rather than risk-averse incremental science.
2. Obstacles to Transformation
Despite the clear vision, these experts highlight significant systemic barriers that prevent optimal outcomes.
The “Slinky Effect”: As you may have been reading I describe the “Slinky Effect” as the invisible, downward spiral of regression that occurs when structured support is withdrawn after discharge. Without long-term monitoring, gains unravel, leading to increased fall risk and sarcopenia.
The Reimbursement Gap: Innovation is stifled because insurance models do not yet value or pay for long-term maintenance or hardware interventions. Vineet Johnson (PT) notes that funding is a major hurdle for hardware startups, as investors prefer software, and insurance companies need proof of long-term economic value before reimbursing devices.
Lack of Ownership: Dr. Kimberley points out that unlike Parkinson’s disease, where a movement disorder neurologist manages care for life, stroke survivors have no single “owner” of their care after discharge, leading to fragmented, random outcomes based on geography and insurance rather than need,.
Broken Clinical Trials: Accessing innovation is difficult. Dr. Jayaraman and Vineet Johnson discuss the difficulty patients face in finding and enrolling in clinical trials, which are often “gatekept” by large hospital systems, preventing widespread adoption of new technologies.
3. The Promise: Technology-Enabled Longitudinal Care
The “promise” for the future lies in shifting care from the clinic into the home, using technology to maintain the intensity of therapy discussed by Dr. Jayaraman and Dr. Kimberley.
Sensor-Based Digital Health Technologies (sDHT): sDHTs are the key to capturing real-world mobility data (gait, steps, sleep) that was previously missing from care plans. These tools can detect early signs of decline (see my ‘Slinky Effect’) and trigger interventions before a fall or hospitalization occurs.
Implants and Vagus Nerve Stimulation (VNS): Dr. Kimberley highlights VNS as a “watershed moment” for stroke, offering a way to boost neuroplasticity by pairing stimulation with intense exercise, effectively doubling the benefits of therapy even years post-stroke.
Robotics and Gamification: Innovators like Vineet Johnson and Dr. Jayaraman are developing “soft robots” and gamified hand devices that patients can take home. These devices focus on “task specificity” and intrinsic motivation, allowing patients to achieve the high repetition counts (neuroplasticity) required for recovery without being tethered to a clinic.
Predictive Analytics: Dr. Jayaraman’s team is working on “Automation, Illumination, and Prediction,” using sensors to predict fall risks and recovery trajectories on day one, allowing clinicians to intervene proactively rather than reactively.
4. Prediction: The “Break Out Moment” for Stroke Care
When will stroke care finally transform? According to my own research, analysis and lived experience as a stroke survivor the collective insights of these experts, the “break out moment” will occur when physical activity is treated and measured as an essential medicine.
The break out depends on integrating Sensor-Based Digital Health Technologies (sDHT) into a connected ecosystem of care. This transition will happen when:
Measurement becomes continuous: Just as diabetes is managed by tracking glucose, stroke must be managed by longitudinally tracking mobility and function via sDHTs.
Data becomes actionable: It is not enough to just collect data; it must be interpreted by stroke-savvy clinicians (PTs/OTs) to create personalized movement prescriptions.
The Consumer becomes the Customer: The model must shift so that survivors are the customers demanding these tools, rather than just the “product” of healthcare systems. This requires industry leaders (like Apple, Oura, and Whoop) to design specifically for the stroke population and for the American Heart and Stroke Association (AHA/ASA) to either genuinely engage with us and listen to us stroke survivors and care partners and fund aftercare support (community based stroke support organizations / or SSOs) or get out of the way and stop the current lip service that you ‘are trying to do more’.
Overcoming Recovery Obstacles:
The “magic wand” answers from our Know Stroke Podcast guests summarized in this article and in my upcoming book chapter reveal that the technology to fix stroke care exists today.
The obstacle is not a lack of science, but a lack of implementation and reimbursement for longitudinal care.
The future of stroke rehabilitation lies in a hybrid model where intense, human-led therapy is amplified by home-based technology, ensuring that recovery is supported not just for months, but for the lifespan as needed.
Sensor-based Digital Health Technologies (sDHTs) are identified by the sources as the critical “missing link” required to transition stroke care from a short-term, acute model to a longitudinal, lifespan approach. By capturing high-resolution, real-world data outside the clinic, sensors serve three primary roles: automating clinical assessments, predicting medical risks, and driving neuroplasticity through immediate feedback.
1. Automation, Illumination, and Prediction (AIP)
Dr. Arun Jayaraman of the Shirley Ryan AbilityLab outlines a specific framework for how sensors function in a hospital and home setting, known as the AIP model:
Automation: Sensors can automate standard clinical outcome measures that typically require a therapist’s time and dedicated equipment. By using “stickable” sensors, clinicians can capture data on gait, balance, heart rate, and respiratory rate automatically,. Dr. Jayaraman notes that a patient can perform a “snapshot activity” for one minute, and the sensors can generate a predicted score for a six-minute walk test or a Berg Balance Scale assessment without the patient undergoing the full, exhausting test.
Illumination: Sensors reveal why a change is occurring. For example, if a patient is walking faster, sensors can illuminate whether this is due to genuine recovery or if the patient is utilizing a pathological gait pattern (a “trick movement”) that might cause long-term orthopedic damage.
Prediction: Perhaps the most critical role for longitudinal monitoring is the ability to predict adverse events. Using machine learning, sensor data collected on day one can help predict a patient’s recovery trajectory and fall risk at discharge, one month, and even one year post-stroke.
2. Preventing the “Slinky Effect”
A major role of sensors is to act as a safety net against the “Slinky Effect”—a term I coined to describe the regression and downward spiral of health that occurs when structured therapy ends and patients return home without oversight.
Real-World Surveillance: Unlike commercial wearables (like standard fitness trackers) which are often trained on healthy adults and may misinterpret stroke movement, medical-grade sDHTs capture specific biomarkers of recovery such as gait quality, sleep patterns, and sedentary behavior.
Early Intervention: Longitudinal monitoring allows care teams to detect early signs of physical decline or stagnation, prompting timely interventions before a fall or hospitalization occurs. Dr. Jayaraman’s team, for instance, has developed “airbag shorts” that use sensors to detect a fall in progress and deploy an airbag to prevent hip fractures, addressing the high fall risk specific to the stroke population.
Radio Frequency Monitoring: For longitudinal monitoring in the home where privacy is a concern (e.g., bathrooms or bedrooms), Dr. Jayaraman highlights technology that uses radio frequency waves rather than cameras. These sensors bounce signals off the body to track movement, sleep quality, and falls through walls without visual intrusion.
3. Enhancing Neuroplasticity and Device Interaction
Sensors play a direct role in therapeutic devices by providing the “closed-loop” feedback necessary for motor learning and neuroplasticity.
Correction and Feedback: Vineet Johnson describes the MyHand system, which uses sensors to detect friction and muscle spindle activity. The device ensures the hand is positioned correctly to induce “effective neuroplasticity” rather than incorrect patterns. The sensors provide real-time data that shows patients their granular progress (e.g., slight increases in finger movement), which drives intrinsic motivation.
Triggering Therapy: In the case of Vagus Nerve Stimulation (VNS), while not a monitoring sensor in the traditional sense, the device utilizes a magnet swipe (a sensor interaction) to trigger therapy cycles at home, allowing patients to pair stimulation with daily tasks like washing dishes.
4. Obstacles and Considerations
While the promise of sensors is high, the sources highlight specific challenges in their implementation:
Placement Accuracy: Dr. Jennifaye Brown notes a critical nuance in longitudinal monitoring: the location of the sensor matters. If a sensor is placed on the less-affected limb, it may record movement intensity for cardiovascular health but fail to accurately track neuroplastic recovery of the hemiparetic (stroke-affected) side.
Data Overload: Simply collecting data is insufficient; it must be interpreted by “stroke-savvy” clinicians to be actionable. The goal is to move beyond raw data to insights that allow therapists to adjust interventions in real-time.
In summary, sensors act as the “connective tissue” in a fragmented healthcare system. They effectively replace the subjective, episodic “snapshot” of a clinic visit with a continuous, objective movie of a survivor’s real-world health, essentially treating physical activity as a measurable, dosable medicine.
To understand why I, as well as others, advocate for applying the “cancer or diabetes model” to stroke care, it is necessary to look at how I view the disparity between how we treat chronic systemic diseases versus how we treat stroke recovery.
My “magic wand” answer centers on the idea that stroke is currently treated as an acute event with a finish line, whereas it should be managed as a lifelong condition requiring ongoing dosage and measurement.
Here is a breakdown of the specific parallels I draws between these conditions to explain the concept of longitudinal surveillance.
1. The “Essential Medicine” Comparison
I’ve long argued that just as other chronic conditions have a primary medical intervention that is dosed and tracked, stroke has a physical equivalent that is currently ignored.
Diabetes: The management tool is insulin and lifestyle change. Success is tracked via biomarkers like A1C levels and circulation.
Cancer: Care involves long-term surveillance, chemotherapy or targeted infusions, and regular monitoring for recurrence.
Stroke: My position is that “mobility and movement” are the stroke survivor’s equivalent to insulin or chemotherapy. I stated in my own magic wand answer that “Physical activity should be treated not as a short-term therapy goal, but as an essential medicine, and with its correct dosing can become a measurable component of long-term brain and body health”.
2. The Missing Pathway: “The Slinky Effect”
The reason I advocate for a surveillance model is to prevent what I call the “Slinky Effect.”
In the current model, stroke survivors are often “parachuted out” of the hospital (a concept echoed by guest Dr. Pamela Duncan) with no long-term plan.
Without the “surveillance” found in diabetes or cancer care, stroke survivors experience a “downward spiral” or regression of progress, similar to a Slinky walking down stairs. This leads to increased fall risks, sarcopenia (muscle loss), and depression.
By adopting a cancer-style surveillance model, the healthcare system would catch this decline early, intervening before a fall or hospitalization occurs, rather than waiting for a new acute event to trigger care.
3. The Mechanism of Surveillance: sDHT
In diabetes, patients use glucose monitors to track their status. I’ll argue that Sensor-Based Digital Health Technologies (sDHT) are the stroke equivalent of the glucose monitor.
Objective Measurement: Just as a diabetic doesn’t guess their blood sugar, a stroke survivor shouldn’t guess their recovery status. sDHTs (wearables, sensors) provide “high-resolution data” on gait quality, steps, and sleep patterns that were previously missing from care plans.
Actionable Insights: This data allows clinicians to provide “correct dosing” of physical activity, transforming it from a vague suggestion into a measurable medical prescription.
4. Alignment with Industry Experts
My advocacy for this model is supported by the consensus of the other PT experts we had interviewed, creating a unified vision for this new pathway:
The Dental Model: Dr. Teresa Jacobson Kimberley supports this longitudinal view by suggesting a “dental model” where stroke survivors get check-ups twice a year for life, ensuring they aren’t “dropped off a cliff”.
Movement for the Lifespan: Dr. Jennifaye Brown echoes the diabetes comparison, noting that sedentary behavior is a driver for diabetes and hypertension, and that physical activity must be engaged in “for the lifetime” to prevent secondary strokes.
Next Steps
The crux of my “magic wand” is to stop treating stroke as a singular injury that heals, and start treating it as a chronic condition that must be managed. By applying the surveillance pathways of cancer and diabetes, the medical community would acknowledge that mobility is medicine, requiring consistent measurement (via sensors) and dosing (via therapy) for the rest of the survivor’s life.
Please chime in! I’ll be carving out a deeper dive in this chapter of my new book along with some new PT playbook templates for recovery to build from.
